Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients
Status:
Completed
Trial end date:
2018-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to ascertain whether Arotinolol Hydrochloride reduces mortality
and cardiovascular events in chronic kidney disease stage 5 patients with hypertension.